Joint Formulary & PAD

Prazosin hydrochloride - Post-traumatic stress disorder (PTSD)

You are here : Home > Formulary Search > Prazosin hydrochloride - Post-traumatic stress disorder (PTSD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Off Label
Restrictions / Comments :
Important

THIRD LINE - following inadequate response to an SSRI and venlafaxine as first- and second-line treatments respectively.

The specialist team will initiate treatment and provide at least a 1 month supply before any request is made to transfer prescribing responsibility to Primary Care.

Documents :
 
Evidence Review
Prazosin for PTSD - Evidence review - Nov 2025

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Prazosin hydrochloride
Indication :
Post-traumatic stress disorder (PTSD)
Group Name :
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

07 Jul 26 - Surrey & Sussex Area Prescribing Committee (APC)

The Surrey & Sussex Integrated Care Board Area Prescribing Committee (APC) approved the addition of prazosin for PTSD (third-line) to the formulary with a BLUE formulary status (specialist initiation and supply for at least one month).

Other Indications

Below are listed other indications that Prazosin hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Post-traumatic stress disorder (PTSD).